Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Mccormick & Company (MKC)

Mccormick & Company (MKC)
77.01 x 1 78.00 x 3
Pre-market by (Cboe BZX)
80.34 +0.17 (+0.21%) 03/24/25 [NYSE]
77.01 x 1 78.00 x 3
Pre-market 77.60 -2.74 (-3.41%) 08:13 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
78.76
Day High
80.79
Open 79.50
Previous Close 80.17 80.17
Volume 2,672,800 2,672,800
Avg Vol 2,454,905 2,454,905
Stochastic %K 14.53% 14.53%
Weighted Alpha +6.15 +6.15
5-Day Change -1.52 (-1.86%) -1.52 (-1.86%)
52-Week Range 66.88 - 86.24 66.88 - 86.24
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,543,490
  • Shares Outstanding, K 268,154
  • Annual Sales, $ 6,724 M
  • Annual Income, $ 788,500 K
  • EBIT $ 1,060 M
  • EBITDA $ 1,269 M
  • 60-Month Beta 0.71
  • Price/Sales 3.20
  • Price/Cash Flow 21.53
  • Price/Book 4.07

Options Overview Details

View History
  • Implied Volatility 26.89% ( +0.94%)
  • Historical Volatility 25.16%
  • IV Percentile 83%
  • IV Rank 56.01%
  • IV High 34.01% on 03/25/24
  • IV Low 17.82% on 05/13/24
  • Put/Call Vol Ratio 0.76
  • Today's Volume 3,559
  • Volume Avg (30-Day) 1,990
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 23,179
  • Open Int (30-Day) 25,158

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/25
See More
  • Average Estimate 0.64
  • Number of Estimates 6
  • High Estimate 0.65
  • Low Estimate 0.61
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +1.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.76 +2.01%
on 03/24/25
Period Open: 81.22
86.24 -6.84%
on 03/10/25
-0.88 (-1.08%)
since 02/24/25
3-Month
70.05 +14.69%
on 01/13/25
Period Open: 78.03
86.24 -6.84%
on 03/10/25
+2.31 (+2.96%)
since 12/24/24
52-Week
66.88 +20.12%
on 06/26/24
Period Open: 70.03
86.24 -6.84%
on 03/10/25
+10.31 (+14.72%)
since 03/22/24

Most Recent Stories

More News
McCormick (NYSE:MKC) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops

McCormick (NYSE:MKC) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops

MKC : 80.34 (+0.21%)
McCormick: Fiscal Q1 Earnings Snapshot

McCormick: Fiscal Q1 Earnings Snapshot

MKC : 80.34 (+0.21%)
Is McCormick Stock Outperforming the Nasdaq?

McCormick has notably outperformed the Nasdaq Composite over the past year and analysts remain bullish on the stock’s prospects.

$NASX : 18,188.59 (+2.27%)
HRL : 29.26 (-2.40%)
MKC : 80.34 (+0.21%)
McCormick (MKC) Q1 Earnings: What To Expect

McCormick (MKC) Q1 Earnings: What To Expect

GIS : 58.17 (-0.80%)
MKC : 80.34 (+0.21%)
Durable Goods, Home Sales in U.S. Due Next Week

U.S. Monday Economic Lookahead S&P flash U.S. services PMI (March) S&P flash ...

CNM : 49.64 (+2.84%)
HUMA : 3.32 (unch)
MKC : 80.34 (+0.21%)
BRZE : 38.11 (+2.92%)
DLTR : 69.74 (+4.48%)
TMC : 1.7800 (-2.20%)
EPAC : 43.38 (+2.67%)
DIV.TO : 2.77 (+1.47%)
KBH : 61.79 (+3.41%)
LULU : 334.96 (+3.82%)
CKPT : 4.05 (-0.49%)
KEI.TO : 10.43 (+1.16%)
Spotting Winners: TreeHouse Foods (NYSE:THS) And Shelf-Stable Food Stocks In Q4

Spotting Winners: TreeHouse Foods (NYSE:THS) And Shelf-Stable Food Stocks In Q4

JJSF : 127.39 (+0.54%)
MKC : 80.34 (+0.21%)
LANC : 175.87 (+0.31%)
LW : 53.93 (+1.60%)
THS : 26.20 (-0.57%)
A Look Back at Shelf-Stable Food Stocks’ Q4 Earnings: Hormel Foods (NYSE:HRL) Vs The Rest Of The Pack

A Look Back at Shelf-Stable Food Stocks’ Q4 Earnings: Hormel Foods (NYSE:HRL) Vs The Rest Of The Pack

HRL : 29.26 (-2.40%)
MKC : 80.34 (+0.21%)
LANC : 175.87 (+0.31%)
LW : 53.93 (+1.60%)
BGS : 6.84 (-3.53%)
Reflecting On Shelf-Stable Food Stocks’ Q4 Earnings: McCormick (NYSE:MKC)

Reflecting On Shelf-Stable Food Stocks’ Q4 Earnings: McCormick (NYSE:MKC)

MKC : 80.34 (+0.21%)
KHC : 29.12 (-1.36%)
LANC : 175.87 (+0.31%)
LW : 53.93 (+1.60%)
BRBR : 73.55 (+4.10%)
McCormick (MKC): Buy, Sell, or Hold Post Q4 Earnings?

McCormick (MKC): Buy, Sell, or Hold Post Q4 Earnings?

MKC : 80.34 (+0.21%)
NET : 123.93 (+3.95%)
Q4 Earnings Outperformers: BellRing Brands (NYSE:BRBR) And The Rest Of The Shelf-Stable Food Stocks

Q4 Earnings Outperformers: BellRing Brands (NYSE:BRBR) And The Rest Of The Shelf-Stable Food Stocks

MKC : 80.34 (+0.21%)
LANC : 175.87 (+0.31%)
LW : 53.93 (+1.60%)
BRBR : 73.55 (+4.10%)
HSY : 168.01 (+0.50%)
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

SUPN : 32.70 (+1.71%)
JNJ : 163.29 (-0.21%)
ZTS : 163.17 (+0.09%)
LLY : 864.90 (+3.26%)
PFE : 26.14 (-0.53%)
Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market.

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
On Sale Now: 20 Blue Chip Stocks to Buy

These 20 blue chip companies are the largest traded on U.S. exchanges.

BABA : 134.48 (-0.49%)
GOOGL : 167.68 (+2.25%)
NVDA : 121.41 (+3.15%)
META : 618.85 (+3.79%)
AVGO : 191.25 (-0.21%)
SAP : 275.74 (+1.18%)
BAC : 43.07 (+1.41%)
KO : 68.95 (+0.41%)
UNH : 516.50 (-0.07%)
ASML : 727.84 (+1.62%)
MSFT : 393.08 (+0.47%)
MA : 543.67 (+1.49%)
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Ignore the noise in GLP-1 stocks. Find the best value instead.

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
RHHBY Enters Into a $5.3B Deal With Zealand Pharma for Obesity Drug

Roche RHHBY announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma for an obesity candidate.Per the terms of the agreement, both companies will develop...

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration...

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?

Shutting down an acquisition caught investor attention, but there's more to the story.

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their medicines and...

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
MS : 124.27 (+3.44%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
Why Eli Lilly Stock Flopped Today

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of their value...

$SPX : 5,767.57 (+1.76%)
LLY : 864.90 (+3.26%)
The Reality of Trump's Tariffs

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss:

TGT : 108.35 (+4.12%)
GOOGL : 167.68 (+2.25%)
GOOG : 169.93 (+2.21%)
AAPL : 220.73 (+1.13%)
OKTA : 116.38 (+2.32%)
TSM : 181.16 (+2.51%)
MSFT : 393.08 (+0.47%)
COST : 926.04 (+1.85%)
AZO : 3,657.82 (+1.43%)
LLY : 864.90 (+3.26%)
HD : 363.77 (+3.59%)
AMZN : 203.26 (+3.59%)
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

SUPN : 32.70 (+1.71%)
JNJ : 163.29 (-0.21%)
ZTS : 163.17 (+0.09%)
LLY : 864.90 (+3.26%)
PFE : 26.14 (-0.53%)
Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market.

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
On Sale Now: 20 Blue Chip Stocks to Buy

These 20 blue chip companies are the largest traded on U.S. exchanges.

BABA : 134.48 (-0.49%)
GOOGL : 167.68 (+2.25%)
NVDA : 121.41 (+3.15%)
META : 618.85 (+3.79%)
AVGO : 191.25 (-0.21%)
SAP : 275.74 (+1.18%)
BAC : 43.07 (+1.41%)
KO : 68.95 (+0.41%)
UNH : 516.50 (-0.07%)
ASML : 727.84 (+1.62%)
MSFT : 393.08 (+0.47%)
MA : 543.67 (+1.49%)
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Ignore the noise in GLP-1 stocks. Find the best value instead.

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
RHHBY Enters Into a $5.3B Deal With Zealand Pharma for Obesity Drug

Roche RHHBY announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma for an obesity candidate.Per the terms of the agreement, both companies will develop...

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration...

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?

Shutting down an acquisition caught investor attention, but there's more to the story.

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their medicines and...

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
MS : 124.27 (+3.44%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
Why Eli Lilly Stock Flopped Today

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of their value...

$SPX : 5,767.57 (+1.76%)
LLY : 864.90 (+3.26%)
The Reality of Trump's Tariffs

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss:

TGT : 108.35 (+4.12%)
GOOGL : 167.68 (+2.25%)
GOOG : 169.93 (+2.21%)
AAPL : 220.73 (+1.13%)
OKTA : 116.38 (+2.32%)
TSM : 181.16 (+2.51%)
MSFT : 393.08 (+0.47%)
COST : 926.04 (+1.85%)
AZO : 3,657.82 (+1.43%)
LLY : 864.90 (+3.26%)
HD : 363.77 (+3.59%)
AMZN : 203.26 (+3.59%)
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

SUPN : 32.70 (+1.71%)
JNJ : 163.29 (-0.21%)
ZTS : 163.17 (+0.09%)
LLY : 864.90 (+3.26%)
PFE : 26.14 (-0.53%)
Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market.

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
On Sale Now: 20 Blue Chip Stocks to Buy

These 20 blue chip companies are the largest traded on U.S. exchanges.

BABA : 134.48 (-0.49%)
GOOGL : 167.68 (+2.25%)
NVDA : 121.41 (+3.15%)
META : 618.85 (+3.79%)
AVGO : 191.25 (-0.21%)
SAP : 275.74 (+1.18%)
BAC : 43.07 (+1.41%)
KO : 68.95 (+0.41%)
UNH : 516.50 (-0.07%)
ASML : 727.84 (+1.62%)
MSFT : 393.08 (+0.47%)
MA : 543.67 (+1.49%)
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Ignore the noise in GLP-1 stocks. Find the best value instead.

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
RHHBY Enters Into a $5.3B Deal With Zealand Pharma for Obesity Drug

Roche RHHBY announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma for an obesity candidate.Per the terms of the agreement, both companies will develop...

NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
RHHBY : 42.9100 (-1.81%)
Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would be shut out of the GLP-1 market, got a reprieve from the Food and Drug Administration...

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?

Shutting down an acquisition caught investor attention, but there's more to the story.

HIMS : 37.41 (+7.65%)
NVO : 75.33 (-1.99%)
LLY : 864.90 (+3.26%)
Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their medicines and...

VKTX : 29.28 (+1.14%)
NVO : 75.33 (-1.99%)
MS : 124.27 (+3.44%)
LLY : 864.90 (+3.26%)
AMGN : 314.38 (-0.53%)
Why Eli Lilly Stock Flopped Today

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of their value...

$SPX : 5,767.57 (+1.76%)
LLY : 864.90 (+3.26%)
The Reality of Trump's Tariffs

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss:

TGT : 108.35 (+4.12%)
GOOGL : 167.68 (+2.25%)
GOOG : 169.93 (+2.21%)
AAPL : 220.73 (+1.13%)
OKTA : 116.38 (+2.32%)
TSM : 181.16 (+2.51%)
MSFT : 393.08 (+0.47%)
COST : 926.04 (+1.85%)
AZO : 3,657.82 (+1.43%)
LLY : 864.90 (+3.26%)
HD : 363.77 (+3.59%)
AMZN : 203.26 (+3.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

McCormick & Company, Inc. is a leading manufacturer, marketer and distributor of spices, seasonings, specialty foods and flavors to the entire food industry across the entire globe. McCormick conducts its business through two segments namely Consumer unit and Flavor Solutions unit. The Consumer Business...

See More

Key Turning Points

3rd Resistance Point 83.19
2nd Resistance Point 81.99
1st Resistance Point 81.16
Last Price 80.34
1st Support Level 79.14
2nd Support Level 77.94
3rd Support Level 77.11

See More

52-Week High 86.24
Last Price 80.34
Fibonacci 61.8% 78.85
Fibonacci 50% 76.56
Fibonacci 38.2% 74.28
52-Week Low 66.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.